Author

Kenneth C. Micetich

Observed names: K C Micetich, K Micetich, K. C. Micetich, K. Micetich, KENNETH C. MICETICH, Kenneth C Micetich, Kenneth Craig Micetich, Kenneth Craig Micetich, Kenneth Micetich

Observed institutions: National Institutes of Health, Loyola University Medical Center, Oregon Health & Science University, University of California, San Francisco, Loyola University Chicago, Yeshiva University, Princess Margaret Cancer Centre, University of Chicago, Fred Hutch Cancer Center, USC Norris Comprehensive Cancer Center, Loyola Medicine, Moores Cancer Center, New York University, University of Pennsylvania

OpenAlex ID: A5048643621

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

2015 · Edgar Ben-Josef, Katherine A. Guthrie, et al. · Journal of Clinical Oncology · 420

Reactivation of Chronic Hepatitis B Virus Infection by Cancer Chemotherapy

1982 · JAY H. HOOFNAGLE, GEOFFREY M. DUSHEIKO, et al. · Annals of Internal Medicine · 394

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma.

1993 · J A Sparano, R I Fisher, et al. · Journal of Clinical Oncology · 176

S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma

2014 · A B El-Khoueiry, C Rankin, et al. · British Journal of Cancer · 122

PDF

Are Intravenous Fluids Morally Required for a Dying Patient?

1983 · K. C. Micetich · Archives of Internal Medicine · 107

A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells.

1985 · K C Micetich, D Barnes, et al. · PubMed · 106

Quenching of DNA:platinum(II) monoadducts as a possible mechanism of resistance to cis-diamminedichloroplatinum(II) in L1210 cells.

1983 · K Micetich, L A Zwelling, et al. · PubMed · 92

Metastatic malignant melanoma treated with combined bolus and continuous infusion interleukin-2 and lymphokine-activated killer cells.

1990 · M H Bar, M Sznol, et al. · Journal of Clinical Oncology · 81

Inhibition of a Specific DNA Repair System and Nitrosourea Cytotoxicity in Resistant Human Cancer Cells

1989 · Bernard W. Futscher, Kenneth C. Micetich, et al. · Cancer Communications · 59

Phase I Study of Streptozocin- and Carmustine-Sequenced Administration in Patients With Advanced Cancer

1992 · K. C. Micetich, B. Futscher, et al. · JNCI Journal of the National Cancer Institute · 45

Final analysis of a randomized phase II study of bevacizumab (B) and gemcitabine (G) plus cetuximab (C) or erlotinib (E) in patients (pts) with advanced pancreatic cancer (PC)

2008 · H. L. Kindler, T. Gangadhar, et al. · Journal of Clinical Oncology · 34

Exaggerated Response to Insect Bites An Unusual Cutaneous Manifestation of Chronic Lymphocytic Leukemia

1989 · Robert V. Kolbusz, Kenneth Micetich, et al. · International Journal of Dermatology · 29

Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors.

2003 · Gladell P Paner, Simone Silberman, et al. · PubMed · 27

Nephrotoxicity of semustine (methyl-CCNU) in patients with malignant melanoma receiving adjuvant chemotherapy

1981 · Kenneth C. Micetich, Michael Jensen-Akula, et al. · The American Journal of Medicine · 24

A randomized phase II study of bevacizumab (B) and gemcitabine (G) plus cetuximab (C) or erlotinib (E) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis

2006 · H. L. Kindler, K. A. Bylow, et al. · Journal of Clinical Oncology · 17

Carboplatin for advanced colorectal carcinoma: a phase II study.

1986 · D J Perry, R B Weiss, et al. · PubMed · 15

Erythema with features of seborrheic dermatitis and lupus erythematosus associated with systemic 5-fluorouracil.

1987 · K Dudley, K Micetich, et al. · PubMed · 14

Competing Clinical Trials in the Same Institution: Ethical Issues in Subject Selection and Informed Consent

2002 · Elisa J. Gordon, Kenneth C. Micetich · IRB Ethics and Human Research · 12

Sweet's syndrome with neurologic manifestations in a patient with esophageal adenocarcinoma: case report and review of the literature

2009 · Urszula A. Sobol, Karen L. Sherman, et al. · International Journal of Dermatology · 11

Cytogenetic effects of amsacrine on human lymphocytes in vivo and in vitro.

1984 · C S Kao-Shan, K Micetich, et al. · PubMed · 11

Phase I-II study of m-AMSA administered as a continuous infusion.

1982 · K C Micetich, L A Zwelling, et al. · PubMed · 11

Reflection of an IRB Chair

1994 · Kenneth Craig Micetich · Cambridge Quarterly of Healthcare Ethics · 7

The Ethics of Patient Requests in Experimental Medicine

1984 · K. C. Micetich, D. C. Thomasma · CA A Cancer Journal for Clinicians · 7

PDF

Preclinical and Clinical Experiences with Drug Combinations Designed to Inhibit DNA Repair in Resistant Human Tumor Cells

1988 · LEONARD C. ERICKSON, KENNETH C. MICETICH, et al. · Elsevier eBooks · 6

The Ethical Problems of the Open Label Extension Study

1996 · Kenneth Craig Micetich · Cambridge Quarterly of Healthcare Ethics · 5

Works count: 38

Citation count: 1,861

H-index: 15

I10-index: 21